Post by
lonc17 on Oct 10, 2023 8:50pm
MM Trial
Curious that ONC has not issued a press release:
https://pubmed.ncbi.nlm.nih.gov/37812476/
Comment by
lonc17 on Oct 10, 2023 8:59pm
Among the 11 response-evaluable patients, 1 had a VGPR, 1 had a PR, 2 had a minor response (MR), 4 had stable disease (SD) lasting at least 1 cycle, and 3 had PD after 1 cycle (Table 1)
Comment by
canadafan on Oct 11, 2023 6:50am
Onc has a few quiet trails on-the- go, beyond the well discussed PanCan & MBc phase 3 ready. The MM just one of them. Are the results worthy of a N.R. ? regardless, with the very high short holdings, and recent general markets uptick, I see a nice run coming. I have been wrong before ( blah blah blah), none the less, more up indicators than down. great week all.